Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

IVIg to Treat Severe Refractory HIT

IVIg to Treat Severe Refractory HIT

FromCHEST Journal Podcasts


IVIg to Treat Severe Refractory HIT

FromCHEST Journal Podcasts

ratings:
Length:
38 minutes
Released:
Nov 22, 2017
Format:
Podcast episode

Description

Anand Padmanabhan, MD, PhD, and editorialist Theodore Warkentin, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the paper by Padamanabhan et al, which describes outcomes in three patients with heparin-induced thrombocytopenia (HIT) who responded well to IVIg therapy.
Released:
Nov 22, 2017
Format:
Podcast episode

Titles in the series (100)

Each month, CHEST hosts a discussion with the author of one or more articles from the current issue, adding context and commentary on the most relevant topics facing those in the fields of pulmonary, critical care, and sleep medicine.